Gold prices bounce off 3-week lows; demand likely longer term
Andreas P. Wagner, the Chief Human Resources Officer at Alignment Healthcare, Inc. (NASDAQ:ALHC), recently sold a portion of his holdings in the company. According to a filing with the Securities and Exchange Commission, Wagner sold 14,878 shares of common stock at a price of $14.38 each, totaling approximately $213,945. This transaction was executed on February 12, 2025. The sale comes as ALHC shares have shown remarkable strength, gaining over 125% in the past year. According to InvestingPro data, the company’s market capitalization now stands at $2.77 billion.
Following the sale, Wagner holds 200,885 shares of Alignment Healthcare. It’s important to note that the sale was made to cover tax withholding obligations related to the vesting of restricted stock units and was not a discretionary trade by Wagner. With the company’s next earnings report due in 14 days, InvestingPro subscribers can access 8 additional key insights and a comprehensive Pro Research Report, helping investors make informed decisions about ALHC’s current valuation and market position.
In other recent news, Alignment Healthcare has been in the spotlight with Stifel analysts upholding their confidence in the company by raising its price target from $14.00 to $16.00. This is attributed to Alignment Healthcare’s robust Annual Enrollment Period (AEP) results and the maintained guidance for 2024 and 2025. The company’s technology-driven Medicare Advantage plan has been a key differentiator, enabling it to gain market share amidst challenges faced by competitors.
Recent developments also highlight a 35% year-on-year increase in health plan membership, with the company forecasting a rise to between 225,000 and 231,000 members by the end of 2025. This aligns with Alignment Healthcare’s ongoing growth strategy.
Stifel analysts have noted that the final year of V28 in 2026 and changes in star rating mechanics in 2027 are expected to provide further opportunities for the company. They also emphasized Alignment’s strategic positioning and technological edge, which they believe will contribute to continued success and market share acquisition in the coming years. The company also reaffirmed its full-year guidance ranges for 2024, indicating confidence in its projected financial performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.